LIFESTANCE HEALTH GROUP INC (LFST) Forecast, Price Target & Analyst Ratings

NASDAQ:LFST • US53228F1012

Current stock price

6.91 USD
+0.12 (+1.77%)
At close:
6.91 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LIFESTANCE HEALTH GROUP INC (LFST).

Forecast Snapshot

Consensus Price Target

Price Target
$9.92
+ 43.51% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
$0.01
Revenue Estimate
395.11M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.35%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$9.92
Upside
+ 43.51%
From current price of $6.91 to mean target of $9.92, Based on 17 analyst forecasts
Low
$7.07
Median
$10.20
High
$12.60

Price Target Revisions

1 Month
9.37%
3 Months
8.02%

Price Target Summary

17 Wall Street analysts provided a forecast for the next 12 months for LFST. The average price target is 9.92 USD. This implies a price increase of 43.51% is expected in the next year compared to the current price of 6.91.
The average price target has been revised upward by 8.02% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

LFST Current Analyst RatingLFST Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

LFST Historical Analyst RatingsLFST Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
82.35%
LFST was analyzed by 17 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about LFST.
In the previous month the buy percentage consensus was at a similar level.
LFST was analyzed by 17 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-06BarclaysMaintains Overweight -> Overweight
2026-02-26UBSMaintains Buy -> Buy
2026-02-26KeybancMaintains Overweight -> Overweight
2026-02-26Canaccord GenuityMaintains Buy -> Buy
2026-02-02BTIGMaintains Buy -> Buy
2025-12-12BTIGMaintains Buy -> Buy
2025-12-09BarclaysInitiate Overweight
2025-11-13BMO CapitalInitiate Outperform
2025-11-07UBSMaintains Buy -> Buy
2025-11-06BTIGMaintains Buy -> Buy
2025-08-08UBSMaintains Buy -> Buy
2025-05-27UBSUpgrade Neutral -> Buy
2025-04-08KeybancInitiate Overweight
2025-04-03Canaccord GenuityInitiate Buy
2024-12-16Goldman SachsUpgrade Neutral -> Buy
2024-11-11BarclaysMaintains Underweight -> Underweight
2024-08-15UBSMaintains Neutral -> Neutral
2024-08-09BarclaysMaintains Underweight -> Underweight
2024-04-22Morgan StanleyReiterate Overweight -> Overweight
2024-03-06JefferiesMaintains Buy -> Buy
2024-03-04Goldman SachsMaintains Neutral -> Neutral
2024-02-29BarclaysMaintains Underweight -> Underweight
2023-11-22Goldman SachsMaintains Neutral -> Neutral
2023-11-17JP MorganMaintains Neutral -> Neutral
2023-08-10JP MorganMaintains Neutral -> Neutral

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
$0.01
Revenue Estimate
395.11M
Revenue Q2Q
18.66%
EPS Q2Q
N/A
Number of Analysts
12

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
1.80%
EPS (1 Month)
-16.63%
EPS (3 Months)
33.40%

Next Earnings Summary

LFST is expected to report earnings on 5/13/2026. The consensus EPS estimate for the next earnings is 0.01 USD and the consensus revenue estimate is 395.11M USD.
The next earnings revenue estimate has been revised upward by 1.8% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2028

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
LFST revenue by date.LFST revenue by date.
1.056B
22.82%		1.251B
18.50%		1.424B
13.85%		1.669B
17.18%		1.903B
14.02%		2.165B
13.77%
EBITDA
YoY % growth
LFST ebitda by date.LFST ebitda by date.
-106.911M
21.91%		39.509M
136.96%		78.901M
99.70%		198.12M
151.10%		243.89M
23.10%		297.06M
21.80%
EBIT
YoY % growth
LFST ebit by date.LFST ebit by date.
-187.348M
9.10%		-31.441M
83.22%		24.148M
176.80%		64.66M
167.77%		115.65M
78.86%		183.92M
59.03%
Operating Margin
LFST operating margin by date.LFST operating margin by date.
-17.75%-2.51%1.70%3.87%6.08%8.50%
EPS
YoY % growth
LFST eps by date.LFST eps by date.
-0.51
16.39%		-0.16
68.63%		0.02
112.50%		0.07
240.02%		0.16
142.13%		0.26
56.93%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		0.010.01
219.03%		0.020.03
-3.68%		0.04
499.70%		0.05
299.91%		0.05
154.61%		0.06
100.04%
Revenue
Q2Q % growth		395.11M
18.66%		409.55M
18.60%		424.06M
16.56%		440.06M
15.14%		446.78M
13.08%		462.91M
13.03%		485.09M
14.39%		508.7M
15.60%
EBITDA
Q2Q % growth		43.237M
181.49%		46.763M
88.47%		51.152M
4.97%		56.227M
-22.80%		53.991M
24.87%		57.597M
23.17%		61.825M
20.87%		67.312M
19.71%
EBIT
Q2Q % growth		10.246M
538.78%		13.742M
565.83%		17.607M
137.61%		21.601M
19.45%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

LFST Yearly Revenue VS EstimatesLFST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
LFST Yearly EPS VS EstimatesLFST Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 -0.4 -0.6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
134.65%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
14.35%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
209.01%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

LIFESTANCE HEALTH GROUP INC / LFST Forecast FAQ

Can you provide the average price target for LIFESTANCE HEALTH GROUP INC stock?

17 analysts have analysed LFST and the average price target is 9.92 USD. This implies a price increase of 43.51% is expected in the next year compared to the current price of 6.91.

Can you provide the upcoming earnings date for LIFESTANCE HEALTH GROUP INC?

LIFESTANCE HEALTH GROUP INC (LFST) will report earnings on 2026-05-13, before the market open.

What are the consensus estimates for LIFESTANCE HEALTH GROUP INC (LFST) next earnings?

The consensus EPS estimate for the next earnings of LIFESTANCE HEALTH GROUP INC (LFST) is 0.01 USD and the consensus revenue estimate is 395.11M USD.

Can you provide the consensus rating for LIFESTANCE HEALTH GROUP INC stock?

The consensus rating for LIFESTANCE HEALTH GROUP INC (LFST) is 82.3529 / 100 . This indicates that analysts generally have a positive outlook on the stock.